PharmaVitae explores Allergan’s prescription pharmaceutical performance and outlook, encompassing corporate strategy, marketed portfolio, pipeline potential, and financial performance over 2017–27.

This Datamonitor Healthcare report contains a PharmaVitae Company Analysis module.